MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells

References

• Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.
   PubMed Web of Science ®Google Scholar
• Argiris A, Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck. 2004;26(5):447–455.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee WH, Kim SW, et al. EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition. Cell Signal. 2018;47:122–130.
   PubMed Web of Science ®Google Scholar
• Qureishi A, Rieunier G, Shah KA, et al. Radioresistant laryngeal cancers upregulate type 1 IGF receptor and exhibit increased cellular dependence on IGF and EGF signaling. Clin Otolaryngol. 2019;44(6):1026–1036.
   PubMed Web of Science ®Google Scholar
• Zhong JT, Yu Q, Zhou SH, et al. GLUT-1 siRNA enhances radiosensitization of laryngeal cancer stem cells via enhanced DNA damage, cell cycle redistribution, and promotion of apoptosis in vitro and in vivo. Onco Targets Ther. 2019;12:9129–9142.
   PubMed Web of Science ®Google Scholar
• Kufe DW. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9(12):874–885i>.
   PubMed Web of Science ®Google Scholar
• Jeannon JP, Stafford FW, Soames JV, et al. Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer. Otolaryngol Head Neck Surg. 2001;124(2):199–202.
   PubMed Web of Science ®Google Scholar
• Jeannon JP, Aston V, Stafford FW, et al. Expression of MUC1 and MUC2 glycoproteins in laryngeal cancer. Clin Otolaryngol Allied Sci. 2001;26(2):109–112.
   PubMed Web of Science ®Google Scholar
• Nath S, Daneshvar K, Roy LD, et al. MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. Oncogenesis. 2013;2:e51.
   PubMed Web of Science ®Google Scholar
• Namba M, Hattori N, Hamada H, et al. Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1. Cancer Lett. 2019;442:31–39.
   PubMed Web of Science ®Google Scholar
• Jain S, Washington A, Leaf RK, et al. Decitabine priming enhances mucin 1 inhibition mediated disruption of redox homeostasis in cutaneous T-cell lymphoma. Mol Cancer Ther. 2017;16(10):2304–2314.
   PubMed Web of Science ®Google Scholar
• Hiramoto K, Yamate Y, Sato EF. Gp91phox NADPH oxidase modulates litter size by regulating mucin1 in the uterus of mice. Syst Biol Reprod Med. 2017;63(2):130–139.
   PubMed Web of Science ®Google Scholar
• Shukla SK, Purohit V, Mehla K, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32(1):71–87.
   PubMed Web of Science ®Google Scholar
• Al-Bataineh MM, Kinlough CL, Poland PA, et al. Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2016;310(6):F569–79.
   PubMed Web of Science ®Google Scholar
• Yi FT, Lu QP. Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling. Oncol Lett. 2017;14(6):7571–7576.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang L, Jiang J, et al. Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer. Cell Cycle. 2020;19(6):652–665.
   PubMed Web of Science ®Google Scholar
• Gunda V, Souchek J, Abrego J, et al. MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clin Cancer Res. 2017;23(19):5881–5891.
   PubMed Web of Science ®Google Scholar
• Sipaul F, Birchall M, Corfield A. What role do mucins have in the development of laryngeal squamous cell carcinoma? A systematic review. Eur Arch Otorhinolaryngol. 2011;268(8):1109–1117.
   PubMed Web of Science ®Google Scholar
• Kang Y, Hirano K, Suzuki N, et al. Increased expression after X-irradiation of MUC1 in cultured human colon carcinoma HT-29 cells. Jpn J Cancer Res. 2000;91(3):324–330.
   PubMedGoogle Scholar
• Sousa AM, Grandgenett PM, David L, et al. Reflections on MUC1 glycoprotein: the hidden potential of isoforms in carcinogenesis. APMIS. 2016;124(11):913–924.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Stojanovska L, Gargosky SE. MUC1 (CD227): a multi-tasked molecule. Cell Mol Life Sci. 2015;72(23):4475–4500.
   PubMed Web of Science ®Google Scholar
• Shiba S, Miki A, Ohzawa H, et al. Functional expression of Mucin1 in human duodenal adenocarcinoma. J Surg Res. 2019;238:79–89.
   PubMed Web of Science ®Google Scholar
• Adil Butt M, Pye H, Haidry RJ, et al. Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. Oncotarget. 2017;8(15):25080–25096.
   PubMedGoogle Scholar
• Farahmand L, Merikhian P, Jalili N, et al. Significant role of MUC1 in development of resistance to currently existing anti-cancer therapeutic agents. Curr Cancer Drug Targets. 2018;18(8):737–748.
   PubMed Web of Science ®Google Scholar
• Ham SY, Kwon T, Bak Y, et al. Mucin 1-mediated chemo-resistance in lung cancer cells. Oncogenesis. 2016;5:e185.
   PubMed Web of Science ®Google Scholar
• Shukla SK, Purohit V, Mehla K, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32(3):392.
   PubMed Web of Science ®Google Scholar
• Philchenkov A. Radiation-induced cell death: signaling and pharmacological modulation. Crit Rev Oncog. 2018;23(1–2):13–37.
   PubMedGoogle Scholar
• Edlich F. BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun. 2018;500(1):26–34.
   PubMed Web of Science ®Google Scholar
• Jin W, Liao X, Lv Y, et al. MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner. Cell Death Dis. 2017;8(8):e2980.
   PubMed Web of Science ®Google Scholar
• Sharma A, Gaidamakova EK, Grichenko O, et al. Across the tree of life, radiation resistance is governed by antioxidant Mn2+, gauged by paramagnetic resonance. Proc Natl Acad Sci U S A. 2017;114(44):E9253–E9260.
   PubMed Web of Science ®Google Scholar
• Nunez MI, McMillan TJ, Valenzuela MT, et al. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol. 1996;39:155–165.
   PubMed Web of Science ®Google Scholar
• Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer. 2008 Dec;8(12):957–967.
   PubMed Web of Science ®Google Scholar
• Panier S, Boulton SJ. Double-strand break repair: 53BP1 comes into focus. Nat Rev Mol Cell Biol. 2014;15:7–18.
   PubMed Web of Science ®Google Scholar
• Fradet-Turcotte A, Canny MD, Escribano-Díaz C, et al. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature. 2013;499:50–54.
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Lottersberger F, Buonomo SB, et al. 53BP1 regulates DSB repair using Rif1 to control 5’ end resection. Science. 2013;339:700–704.
   PubMed Web of Science ®Google Scholar